• ARS Pharmaceuticals Announces FDA Acceptance of NDA for neffy® for the Treatment of Allergic Reactions Including Anaphylaxis

    1 month ago - By San Diego Biotechnology

    SAN DIEGO--ARS Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has accepted for review ARS' New Drug Application for neffy for the emergency treatment of allergic reactions ...
    Read more ...